Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank Disease ID
1 African trypanosomiasis 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
2 African trypanosomiasis 💬
[1] IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
3 AGE-RAGE signaling pathway in diabetic complications 💬
[2] IL1A, IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
4 AGE-RAGE signaling pathway in diabetic complications 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
5 Alcoholic liver disease 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
6 Alcoholic liver disease 💬
[1] IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
7 Alzheimer disease 💬
[2] IL1A, IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
8 Alzheimer disease 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
9 Alzheimer disease 💬
[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Colchicine 💬 Colchicine [9]  2 , 42, 46, 50, 56, 93, 97, 210, 266 💬
10 Amoebiasis 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
11 Amoebiasis 💬
[1] IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
12 Amoebiasis 💬
[2] IL1R1, IL1R2 💬 Anakinra 💬 Anakinra [22]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬
13 Amyotrophic lateral sclerosis 💬
[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Colchicine 💬 Colchicine [9]  2 , 42, 46, 50, 56, 93, 97, 210, 266 💬
14 C-type lectin receptor signaling pathway 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
15 C-type lectin receptor signaling pathway 💬
[1] IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
16 Cellular senescence 💬
[1] IL1A 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
17 Chagas disease 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
18 Chagas disease 💬
[1] IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
19 Coronavirus disease 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
20 Coronavirus disease 💬
[1] IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
21 Coronavirus disease 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [26]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
22 Cytokine-cytokine receptor interaction 💬
[2] IL1A, IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
23 Cytokine-cytokine receptor interaction 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
24 Cytokine-cytokine receptor interaction 💬
[2] IL1R1, IL1R2 💬 Anakinra 💬 Anakinra [22]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬
25 Cytokine-cytokine receptor interaction 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [26]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
26 Cytosolic DNA-sensing pathway 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
27 Cytosolic DNA-sensing pathway 💬
[1] IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
28 Fluid shear stress and atherosclerosis 💬
[2] IL1A, IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
29 Fluid shear stress and atherosclerosis 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
30 Fluid shear stress and atherosclerosis 💬
[2] IL1R1, IL1R2 💬 Anakinra 💬 Anakinra [22]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬
31 Gap junction 💬
[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Colchicine 💬 Colchicine [9]  2 , 42, 46, 50, 56, 93, 97, 210, 266 💬
32 Graft-versus-host disease 💬
[2] IL1A, IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
33 Graft-versus-host disease 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
34 Hematopoietic cell lineage 💬
[2] IL1A, IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
35 Hematopoietic cell lineage 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
36 Hematopoietic cell lineage 💬
[2] IL1R1, IL1R2 💬 Anakinra 💬 Anakinra [22]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬
37 Hematopoietic cell lineage 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [26]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
38 Herpes simplex virus 1 infection 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
39 Herpes simplex virus 1 infection 💬
[1] IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
40 HIF-1 signaling pathway 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [26]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
41 Human cytomegalovirus infection 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
42 Human cytomegalovirus infection 💬
[1] IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
43 Human cytomegalovirus infection 💬
[1] IL1R1 💬 Anakinra 💬 Anakinra [22]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬
44 Human cytomegalovirus infection 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [26]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
45 Human T-cell leukemia virus 1 infection 💬
[2] IL1R1, IL1R2 💬 Anakinra 💬 Anakinra [22]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬
46 Huntington disease 💬
[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Colchicine 💬 Colchicine [9]  2 , 42, 46, 50, 56, 93, 97, 210, 266 💬
47 IgSF CAM signaling 💬
[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Colchicine 💬 Colchicine [9]  2 , 42, 46, 50, 56, 93, 97, 210, 266 💬
48 IL-17 signaling pathway 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
49 IL-17 signaling pathway 💬
[1] IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
50 Inflammatory bowel disease 💬
[2] IL1A, IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
51 Inflammatory bowel disease 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
52 Inflammatory mediator regulation of TRP channels 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
53 Inflammatory mediator regulation of TRP channels 💬
[1] IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
54 Inflammatory mediator regulation of TRP channels 💬
[1] IL1R1 💬 Anakinra 💬 Anakinra [22]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬
55 Influenza A 💬
[2] IL1A, IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
56 Influenza A 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
57 JAK-STAT signaling pathway 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [26]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
58 Legionellosis 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
59 Legionellosis 💬
[1] IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
60 Leishmaniasis 💬
[2] IL1A, IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
61 Leishmaniasis 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
62 Lipid and atherosclerosis 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
63 Lipid and atherosclerosis 💬
[1] IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
64 Malaria 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
65 Malaria 💬
[1] IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
66 MAPK signaling pathway 💬
[2] IL1A, IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
67 MAPK signaling pathway 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
68 MAPK signaling pathway 💬
[1] IL1R1 💬 Anakinra 💬 Anakinra [22]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬
69 Measles 💬
[2] IL1A, IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
70 Measles 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
71 Motor proteins 💬
[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Colchicine 💬 Colchicine [9]  2 , 42, 46, 50, 56, 93, 97, 210, 266 💬
72 Necroptosis 💬
[2] IL1A, IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
73 Necroptosis 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
74 NF-kappa B signaling pathway 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
75 NF-kappa B signaling pathway 💬
[1] IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
76 NF-kappa B signaling pathway 💬
[1] IL1R1 💬 Anakinra 💬 Anakinra [22]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬
77 NOD-like receptor signaling pathway 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
78 NOD-like receptor signaling pathway 💬
[1] IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
79 Non-alcoholic fatty liver disease 💬
[2] IL1A, IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
80 Non-alcoholic fatty liver disease 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
81 Non-alcoholic fatty liver disease 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [26]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
82 Osteoclast differentiation 💬
[2] IL1A, IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
83 Osteoclast differentiation 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
84 Osteoclast differentiation 💬
[1] IL1R1 💬 Anakinra 💬 Anakinra [22]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬
85 Parkinson disease 💬
[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Colchicine 💬 Colchicine [9]  2 , 42, 46, 50, 56, 93, 97, 210, 266 💬
86 Pathogenic Escherichia coli infection 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
87 Pathogenic Escherichia coli infection 💬
[1] IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
88 Pathogenic Escherichia coli infection 💬
[1] IL1R1 💬 Anakinra 💬 Anakinra [22]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬
89 Pathogenic Escherichia coli infection 💬
[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Colchicine 💬 Colchicine [9]  2 , 42, 46, 50, 56, 93, 97, 210, 266 💬
90 Pathways in cancer 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [26]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
91 Pathways of neurodegeneration - multiple diseases 💬
[2] IL1A, IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
92 Pathways of neurodegeneration - multiple diseases 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
93 Pathways of neurodegeneration - multiple diseases 💬
[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Colchicine 💬 Colchicine [9]  2 , 42, 46, 50, 56, 93, 97, 210, 266 💬
94 Pertussis 💬
[2] IL1A, IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
95 Pertussis 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
96 Phagocytosis 💬
[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Colchicine 💬 Colchicine [9]  2 , 42, 46, 50, 56, 93, 97, 210, 266 💬
97 PI3K-Akt signaling pathway 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [26]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
98 Prion disease 💬
[2] IL1A, IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
99 Prion disease 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
100 Prion disease 💬
[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Colchicine 💬 Colchicine [9]  2 , 42, 46, 50, 56, 93, 97, 210, 266 💬
101 Prostate cancer 💬
[1] IL1R2 💬 Anakinra 💬 Anakinra [22]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬
102 Rheumatoid arthritis 💬
[2] IL1A, IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
103 Rheumatoid arthritis 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
104 Salmonella infection 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
105 Salmonella infection 💬
[1] IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
106 Salmonella infection 💬
[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 Colchicine 💬 Colchicine [9]  2 , 42, 46, 50, 56, 93, 97, 210, 266 💬
107 Shigellosis 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
108 Shigellosis 💬
[1] IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
109 Shigellosis 💬
[1] IL1R1 💬 Anakinra 💬 Anakinra [22]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬
110 Th17 cell differentiation 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
111 Th17 cell differentiation 💬
[1] IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
112 Th17 cell differentiation 💬
[1] IL1R1 💬 Anakinra 💬 Anakinra [22]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬
113 Th17 cell differentiation 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [26]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
114 TNF signaling pathway 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
115 TNF signaling pathway 💬
[1] IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
116 Toll-like receptor signaling pathway 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
117 Toll-like receptor signaling pathway 💬
[1] IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
118 Transcriptional misregulation in cancer 💬
[1] IL1R2 💬 Anakinra 💬 Anakinra [22]  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬
119 Tuberculosis 💬
[2] IL1A, IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
120 Tuberculosis 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
121 Type I diabetes mellitus 💬
[2] IL1A, IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬
122 Type I diabetes mellitus 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
123 Viral protein interaction with cytokine and cytokine receptor 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [26]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
124 Yersinia infection 💬
[1] IL1B 💬 Canakinumab 💬 Canakinumab [11] 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
125 Yersinia infection 💬
[1] IL1B 💬 Rilonacept 💬 Rilonacept [5] 51, 84, 106, 107, 266 💬